“The Challenge Facing Renal Artery Revascularization: What Have we Not Proven and Why we Must?”

Abstract

Endovascular renal artery stent therapy for atherosclerotic renal artery stenosis (RAS) is associated with excellent acute technical success, low complication rates and acceptable long-term patency. However, the clinical benefits to patients of renal artery stenting remain uncertain.

To facilitate debate regarding the treatment of RAS, we need to understand the epidemiology, basic physiology and clinical consequences of renal artery stenosis. We must attempt to determine which patients are likely to benefit from renal artery stenting, assess the nuances of the percutaneous procedure and review the current literature pertaining to renal artery stenting.

Key Words:

• Renal artery
• Revascularization
• stenting.

Additional information

Notes on contributors

M.R. Jaff

Michael R. Jaff, DO Associate Professor of Medicine Harvard Medical School Medical Director, Vascular Center Massachusetts General Hospital, Boston MA Tel.: [phone] Fax: [phone] E-mail: [email protected]